Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
994 INR | +2.00% | -0.17% | +22.43% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.43% | 208.99Cr | |
+29.98% | 68TCr | |
+30.34% | 59TCr | |
-3.52% | 36TCr | |
+18.59% | 33TCr | |
+4.07% | 28TCr | |
+16.21% | 24TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+7.09% | 17TCr |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Transcript : NATCO Pharma Limited, Q1 2024 Earnings Call, Aug 10, 2023